Intra-arterial catheter for drug delivery

• US 20060047261A1
• Filed: 06/28/2004
• Published: 03/02/2006
• Est. Priority Date: 06/28/2004
• Status: Abandoned Application

• Current Assignee: Trustees Of Columbia University In The City Of New York (Columbia University)
• Original Assignee: Trustees Of Columbia University In The City Of New York (Columbia University)
• Inventors: Joshi, Shailendra
• Application Number:
  US10/879,850
• Publication Number:
  US 20060047261A1
• Time in Patent Office: Days
• US Class Current: 604/509
• CPC Class Codes: A61M 2025/0042 Microcatheters, cannula or the like having outside diameters around 1 mm or less
• CPC Class Codes: A61M 2025/1052 for temporarily occluding a vessel for isolating a sector
• CPC Class Codes: A61M 25/10 Balloon catheters A61M25/0125 takes precedence; embolectomy A61B17/22032; retractors A61B17/02; inflatable balloons for placing stents or stent-grafts A61F2/958 ; stomach balloons for treatment of obesity A61F5/0003; oesophagal tubes A61J15/00
• CPC Class Codes: A61M 25/10184 Means for controlling or monitoring inflation or deflation
• CPC Class Codes: A61M 25/10188 Inflation or deflation data displays

Abstract

The present invention provides a catheter, a drug delivery system and methods for the localized delivery of therapeutic or diagnostic agent to a target location in a subject and methods for the treatment of a pathological disorder in a subject using the same.

Claims

1. A steerable device comprising or which comprises a proximal double-lumen assembly and a balloon, wherein the first lumen of the double-lumen assembly is a micro-catheter and the second lumen of the double-lumen assembly is a larger lumen for inflating and deflating the balloon, and wherein the balloon can be rapidly inflated and deflated.

2. The steerable device of claim 1, wherein the proximal double-lumen assembly is about 4-5.5 French in diameter for the first 80-100 cm.

3. The steerable device of claim 2, wherein the diameter of the proximal double-lumen assembly is gradually narrowed to about 2-3 French in the distal end.

4. The steerable device of claim 1, wherein the micro-catheter is extended beyond the distal end of the balloon.

5. The steerable device of claim 4, wherein the micro-catheter is extended 1-10 cm beyond the distal end of the balloon.

6. The steerable device of claim 1, wherein the micro-catheter is about 1-1.5 French in diameter.

7. The steerable device of claim 1, wherein the balloon is about 1-1.5 cm in length.

8. The steerable device of claim 1, wherein the catheter is made of a material which renders the steerable device strong enough to withstand repeated inflation and deflation of the balloon, flexible enough to negotiate the curve of blood vessels, and having low frictional resistance and thrombogenic potential.

9. The steerable device of claim 1, wherein the steerable device is made of a material with high tensile strength.

10. The steerable device of claim 9, wherein the high tensile strength material is selected from the group consisting of Teflon, nylon, polyurethane, and polyethylene.

11. The steerable device of claim 1, wherein the steerable device has a surface coating.

12. The steerable device of claim 11, wherein the surface coating is hydrophilic.

13. A drug delivery system comprising a steerable device and a balloon drive, wherein the steerable device comprises a proximal double-lumen assembly and a balloon, wherein the first lumen of the double-lumen assembly is a micro-catheter and the second lumen of the double-lumen assembly is a larger lumen for inflating and deflating the balloon, and wherein the balloon can be rapidly inflated and deflated.

14. The drug delivery system of claim 13, wherein the proximal double-lumen assembly is about 4-5 French in diameter for the first 80-100 cm.

15. The drug delivery system of claim 14, wherein the diameter of the proximal double-lumen assembly is gradually narrowed to about 2-3 French in the distal end.

16. The drug delivery system of claim 13, wherein the micro-catheter is extended beyond the distal end of the balloon.

17. The drug delivery system of claim 16, wherein the micro-catheter is extended 1-10 cm beyond the distal end of the balloon.

18. The drug delivery system of claim 13, wherein the micro-catheter is about 1-1.5 French in diameter.

19. The drug delivery system of claim 13, wherein the balloon is about 1-1.5 cm in length.

20. The drug delivery system of claim 13, wherein the steerable device is made of a material which renders the steerable device strong enough to withstand repeated inflation and deflation of the balloon, flexible enough to negotiate the curve of blood vessels, and having low frictional resistance and thrombogenic potential.

21. The drug delivery system of claim 13, wherein the steerable device is made of a material with high tensile strength.

22. The drug delivery system of claim 21, wherein the high tensile strength material is selected from the group consisting of Teflon, nylon, polyurethane and polyethylene.

23. The drug delivery system of claim 13, wherein the steerable device has a surface coating.

24. The drug delivery system of claim 23, wherein the surface coating is hydrophilic.

25. The drug delivery system of claim 13, wherein the balloon drive controls the inflation and deflation of the balloon.

26. The drug delivery system of claim 13, further comprising a computerized device, wherein the computerized device controls the balloon drive.

27. The drug delivery system of claim 26, wherein the primary parameters used by the computerized device to control the balloon drive are the frequency, duration and volume of inflation/deflation.

28. The drug delivery system of claim 13, wherein the balloon is inflated by a radio-opaque low viscosity fluid.

29. The drug delivery system of claim 13, wherein the balloon can be inflated or deflated in about 1 second.

30. A method for the localized delivery of at least one agent to a target location within a subject, comprising the steps of:

(1) partially or completely arresting blood flow to the target location for a short period of time;

(2) delivering the at least one agent in bolus to the target location; and

(3) partially or completely restoring blood flow to the target tissue,

(4) wherein the blood flow is arrested by occluding the artery to the target tissue.

31. The method of claim 30, wherein the steps of (1)-(3) are repeated at least once.

32. The method of claim 30, wherein the blood flow is arrested by inflating a balloon and restored by deflating the balloon.

33. The method of claim 32, wherein the balloon is inflated or deflated in about 1 second.

34. The method of claim 32, wherein a balloon drive controls the inflation and deflation of the balloon.

35. The method of claim 34, wherein a computerized device controls the balloon drive.

36. The method of claim 32, wherein the duration of the balloon inflation is about 10-50 seconds.

37. The method of claim 30, wherein the ventilation of the subject is increased.

38. The method of claim 30, wherein the at least one agent is delivered using a steerable device.

39. The method of claim 38, wherein the steerable device comprises a proximal double-lumen assembly and a balloon, wherein the first lumen of the double-lumen assembly is a micro-catheter and the second lumen of the double-lumen assembly is a larger lumen for inflating and deflating the balloon, and wherein the balloon can be rapidly inflated and deflated.

40. The method of claim 30, the at least one agent is a therapeutic or diagnostic agent.

41. The method of claim 40, wherein the therapeutic agent is selected from the group consisting of an agent for treating brain-related disorders, a chemotherapeutic agent, and a gene-therapy agent.

42. The method of claim 30, wherein the target location is in or close to a tissue in the subject, wherein the tissue has a pathological condition.

43. The method of claim 42, wherein the target location is the artery in or near brain, a tumor, or a tissue in need of gene-therapy.

44. The method of claim 30, wherein the subject is a mammal.

45. The method of claim 30, wherein the subject is a human.

46. A method for the localized delivery of at least one agent to a target location within a subject, comprising the steps of:

(1) providing a drug delivery system comprises a steerable device and a balloon drive, wherein the catheter comprises a proximal double-lumen assembly and a balloon, wherein the first lumen of the double-lumen assembly is a micro-catheter and the second lumen of the double-lumen assembly is a larger lumen for inflating and deflating the balloon, and wherein the balloon can be rapidly inflated and deflated;

(2) incorporating the at least one agent into the drug delivery system; and

(3) delivering the at least one agent to the target location.

47. The method of claim 46, wherein the micro-catheter is extended beyond the distal end of the balloon.

48. The method of claim 46, wherein the steerable device is made of a material with high tensile strength.

49. The method of claim 48, wherein the high tensile strength material is selected from the group consisting of Teflon, nylon, polyurethane, and polyethylene.

50. The method of claim 46, wherein the steerable device has a surface coating.

51. The method of claim 50, wherein the surface coating is hydrophilic.

52. The method of claim 46, wherein the balloon drive controls the inflation and deflation of the balloon.

53. The method of claim 46, further comprising a computerized device, wherein the computerized device controls the balloon drive.

54. The method of claim 53, wherein the primary parameters used by the computerized device to control the balloon drive are the frequency, duration and volume of inflation/deflation.

55. The method of claim 46, wherein the balloon is inflated by a radio-opaque low viscosity fluid.

56. The method of claim 46, wherein the balloon can be inflated or deflated in about 1 second.

57. The method of claim 46, wherein the duration of the balloon inflation is about 10-50 seconds.

58. The method of claim 46, wherein the balloon is rapidly inflated and deflated at least once.

59. The method of claim 46, wherein the balloon inflation partially or completely arrests the blood flow to the target location.

60. The method of claim 46, wherein the ventilation of the subject is increased.

61. The method of claim 46, the at least one agent is a therapeutic or diagnostic agent.

62. The method of claim 61, wherein the therapeutic agent is selected from the group consisting of an agent for treating brain-related disorders, a chemotherapeutic agent, and a gene-therapy agent.

63. The method of claim 46, wherein the at least one agent is delivered to the target location in bolus.

64. The method of claim 46, wherein the target location is in or close to a tissue in the subject, wherein the tissue has a pathological condition.

65. The method of claim 64, wherein the target location is the artery in or near brain, a tumor, or a tissue in need of gene-therapy.

66. The method of claim 46, wherein the subject is a mammal.

67. The method of claim 46, wherein the subject is a human.

68. A method for the localized delivery of an agent to a target location within a subject, comprising the steps of:

(1) providing a drug delivery system comprises a catheter and a balloon drive, wherein the catheter comprises a proximal double-lumen assembly and a balloon, wherein the first lumen of the double-lumen assembly is a micro-catheter and the second lumen of the double-lumen assembly is a larger lumen for inflating and deflating the balloon, and wherein the balloon can be rapidly inflated and deflated;

(2) incorporating the agent into the drug delivery system;

(3) occluding blood flow to the target location by inflating the balloon;

(4) delivering the agent in bolus to the target location; and

(5) deflating the balloon after a short period of time.

69. A method for the treatment of a pathological disorder in a subject, comprising the steps of:

(1) partially or completely arresting blood flow to a target tissue for a short period of time;

(2) delivering at least one therapeutic agent in bolus; and

(3) partially or completely restoring blood flow to the target tissue, wherein the target tissue has a pathological condition and the blood flow is arrested by occluding the artery to the target tissue, and wherein the at least one therapeutic agent is delivered into the target tissue or a location within the artery which is close to the target tissue.

70. The method of claim 69, wherein the steps of (1)-(3) are repeated at least once.

71. The method of claim 69, wherein the blood flow is arrested by inflating a balloon and restored by deflating the balloon.

72. The method of claim 71, wherein the balloon is inflated or deflated in about 1 second.

73. The method of claim 71, wherein a balloon drive controls the inflation and deflation of the balloon.

74. The method of claim 73, wherein a computerized device controls the balloon drive.

75. The method of claim 71, wherein the duration of the balloon inflation is about 10-50 seconds.

76. The method of claim 69, wherein the ventilation of the subject is increased.

77. The method of claim 69, wherein the at least one therapeutic agent is delivered using a steerable device.

78. The method of claim 77, wherein the steerable device comprises a proximal double-lumen assembly and a balloon, wherein the first lumen of the double-lumen assembly is a micro-catheter and the second lumen of the double-lumen assembly is a larger lumen for inflating and deflating the balloon, and wherein the balloon can be rapidly inflated and deflated.

79. The method of claim 69, wherein the target tissue is brain, a tumor, or a tissue in need of gene-therapy.

80. The method of claim 69, wherein the subject is a mammal.

81. The method of claim 69, wherein the subject is a human.

82. A method for the treatment of a pathological disorder in a subject, comprising the steps of:

(1) providing a drug delivery system comprises a steerable device and a balloon drive, wherein the steerable device comprises a proximal double-lumen assembly and a balloon, wherein the first lumen of the double-lumen assembly is a micro-catheter and the second lumen of the double-lumen assembly is a larger lumen for inflating and deflating the balloon, and wherein the balloon can be rapidly inflated and deflated;

(2) incorporating at least one therapeutic agent into the drug delivery system; and

(3) delivering the at least one therapeutic agent to a target location, wherein the target location is in or close to a target tissue in the subject, wherein the target tissue has a pathological condition.

83. The method of claim 82, wherein the micro-catheter is extended beyond the distal end of the balloon.

84. The method of claim 82, wherein the catheter is made of a material with high tensile strength.

85. The method of claim 84, wherein the high tensile strength material is selected from the group consisting of Teflon, nylon, polyurethane, and polyethylene.

86. The method of claim 82, wherein the catheter has a surface coating.

87. The method of claim 86, wherein the surface coating is hydrophilic.

88. The method of claim 82, wherein the balloon drive controls the inflation and deflation of the balloon.

89. The method of claim 82, further comprising a computerized device, wherein the computerized device controls the balloon drive.

90. The method of claim 89, wherein the primary parameters used by the computerized device to control the balloon drive are the frequency, duration, and volume of inflation/deflation.

91. The method of claim 82, wherein the balloon is inflated by a radio-opaque low viscosity fluid.

92. The method of claim 82, wherein the balloon can be inflated or deflated in about 1 second.

93. The method of claim 82, wherein the duration of the balloon inflation is about 10-50 seconds.

94. The method of claim 82, wherein the balloon inflation partially or completely blocks the blood flow to the target location.

95. The method of claim 82, wherein the balloon is rapidly inflated and deflated at least once.

96. The method of claim 82, wherein the ventilation of the subject is increased.

97. The method of claim 82, wherein the at least one therapeutic agent is selected from the group consisting of an agent for treating brain-related disorders, a chemotherapeutic agent, and a gene-therapy agent.

98. The method of claim 82, wherein the target location is the artery in or near brain, a tumor, or a tissue in need of gene-therapy.

99. The method of claim 82, wherein the therapeutic agent is delivered to the target location in bolus.

100. The method of claim 82, wherein the subject is a mammal.

101. The method of claim 82, wherein the subject is a human.

102. A method for the treatment of a pathological disorder in a subject, comprising the steps of:

(1) providing a drug delivery system comprises a catheter and a balloon drive, wherein the catheter comprises a proximal double-lumen assembly and a balloon, wherein the first lumen of the double-lumen assembly is a micro-catheter and the second lumen of the double-lumen assembly is a larger lumen for inflating and deflating the balloon, and wherein the balloon can be rapidly inflated and deflated;

(2) incorporating at least one therapeutic agent into the drug delivery system;

(3) occluding blood flow to the target location by inflating the balloon;

(4) delivering the at least one therapeutic agent to the target location; and

(5) deflating the balloon after a short period of time.

103. The method of claim 102, wherein the steps (3)-(5) are repeated at least once.